HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristian Borg Selected Research

Dinoprostone (PGE2)

1/2014Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristian Borg Research Topics

Disease

13Postpoliomyelitis Syndrome (Post-Polio Syndrome)
09/2015 - 12/2002
10Pain (Aches)
01/2022 - 03/2006
8Poliomyelitis (Polio)
10/2016 - 12/2002
7Inflammation (Inflammations)
04/2015 - 01/2003
2Mental Disorders (Mental Disorder)
01/2022 - 01/2021
2Brain Injuries (Brain Injury)
10/2021 - 07/2019
2Myositis (Idiopathic Inflammatory Myopathies)
06/2012 - 05/2004
2Polymyositis
06/2012 - 05/2004
2Dermatomyositis (Dermatopolymyositis)
06/2012 - 05/2004
2Neuroinflammatory Diseases
01/2009 - 12/2002
1Huntington Disease (Huntington's Disease)
01/2021
1Fatigue
07/2019
1Coronary Disease (Coronary Heart Disease)
04/2015
1Fibromyalgia (Fibrositis)
07/2014
1Peripheral Nervous System Diseases (PNS Diseases)
07/2014
1Diabetes Mellitus
07/2014
1Complex Regional Pain Syndromes
07/2014
1Chronic Pain
07/2014
1Infections
01/2014
1Muscular Diseases (Myopathy)
07/2011
1Spinal Cord Injuries (Spinal Cord Injury)
07/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
04/2011
1Schizophrenia (Dementia Praecox)
04/2011
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
09/2008
1Demyelinating Diseases (Demyelinating Disease)
09/2008
1Nervous System Diseases (Neurological Disorders)
09/2008
1Chronic Renal Insufficiency
11/2005

Drug/Important Bio-Agent (IBA)

8Intravenous Immunoglobulins (IVIG)FDA Link
09/2015 - 05/2004
6CytokinesIBA
07/2012 - 12/2002
4Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2004
3Biomarkers (Surrogate Marker)IBA
04/2011 - 09/2008
2Protein Isoforms (Isoforms)IBA
01/2021 - 09/2008
2Pharmaceutical PreparationsIBA
07/2014 - 09/2003
2Biological ProductsIBA
01/2014 - 06/2012
2Analgesics (Analgesic Drugs)IBA
03/2007 - 03/2006
1APTIBA
10/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
09/2015
1Triglycerides (Triacylglycerol)IBA
04/2015
1CholesterolIBA
04/2015
1LipidsIBA
04/2015
1HDL LipoproteinsIBA
04/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2015
1Immunoglobulin G (IgG)IBA
07/2014
1AutoantibodiesIBA
07/2014
1Antigen-Antibody Complex (Immune Complex)IBA
01/2014
1Dinoprostone (PGE2)FDA Link
01/2014
1EnzymesIBA
01/2014
1ProstaglandinsIBA
01/2014
1InterleukinsIBA
06/2012
1Interleukin-15 Receptors (Interleukin 15 Receptor)IBA
06/2012
1Interleukin-15 (Interleukin 15)IBA
06/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2011
1Tyrosine (L-Tyrosine)FDA Link
04/2011
1Peroxidase (Myeloperoxidase)IBA
12/2010
1coenzyme Q10 (CoQ10)IBA
10/2008
1Trinitrotoluene (TNT)IBA
09/2008
1Troponin T (Troponin T1)IBA
09/2008
1Botulinum Toxins (Botulinum Toxin)IBA
05/2006
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2004
1Prednisolone (Predate)FDA LinkGeneric
05/2004
1Messenger RNA (mRNA)IBA
12/2002

Therapy/Procedure

3Therapeutics
05/2006 - 09/2003
2Pain Management
01/2022 - 10/2017
2Medical Day Care (Partial Hospitalization)
01/2021 - 07/2019
2Resistance Training
10/2008 - 11/2005
1Vocational Rehabilitation
10/2016
1Physical Therapy Modalities (Physical Therapy Technique)
01/2014
1Denervation
07/2012
1Aftercare (After-Treatment)
11/2011
1Activities of Daily Living (ADL)
05/2006